Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesAmgen Announces Overall Survival Results for Vectibix in First-Line Metastatic Colorectal Cancer
Amgen, 11/06/09
Amgen announced that the Phase 3 PRIME "203" trial evaluating Vectibix (panitumumab) administered in combination with FOLFOX (an oxaliplatin–based chemotherapy) as a first–line treatment of metastatic colorectal cancer (mCRC) failed to meet a secondary endpoint of overall survival.
Today in Drug Trials...keeping you current
Receive free subspecialty "5-minute updates" via email
A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
New England Journal of Medicine, 11/20/09
Intravenous Drug Administration During Out-of-Hospital Cardiac Arrest: A Randomized Trial
JAMA, 11/25/09
Abbott to Acquire Novel Investigational Biologic to Treat Chronic Pain
Abbott, 11/16/09
Sponsor
Article Search
Sponsor